Literature DB >> 375752

Secretion of an insulinotropic factor from isolated, perfused rat intestine.

S R Levin, M Z Pehlevanian, A E Lavee, R I Adachi.   

Abstract

To examine gut-islet interrelationships, we entirely separated the gastrointestinal tract from the rat. When we arterially perfused this preparation with an erythrocyte-free solution for 1 h, it remained histologically intact and took up oxygen and glucose. Feedings were given via a duodenal tube. The gut absorbed glucose when glucose in the feeding was high (9.2 g/dl), but not when glucose in the feeding was low (58 mg/dl). With feeding, the portal venous effluent (PVE) from this preparation (stomach to ileum) enhanced late-phase, glucose-induced insulin secretion from pancreas of another rat. This enhancement occurred when the gut was fed either glucose (9.2 g/dl) in electrolyte solution or electrolyte solution alone. PVE from glucose-fed upper gut (stomach, duodenum) was similarly insulinotropic. In contrast, PVE from unfed gut or from glucose-fed gut of old rats was not insulinotropic. PVE from all gut preparations except upper gut produced a glucagon "spike" during basal pancreatic perfusion. Effects of gastrointestinal peptides (gastric inhibitory polypeptide, cholecystokinin octapeptide, secretin, gastrin) and immunoassays of PVE suggested that the insulinotropic substance is not one of these peptides. Thus, an insulinotropic substance that is not dependent on feeding nutrient material is secreted from the intestine.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 375752     DOI: 10.1152/ajpendo.1979.236.6.E710

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  In vitro study on the contribution of the rat intestine-pancreas to glucose homeostasis.

Authors:  M A Tormo; M A Zubeldia; J L Montero; J E Campillo
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

Review 2.  New developments in the incretin concept.

Authors:  W Creutzfeldt; R Ebert
Journal:  Diabetologia       Date:  1985-08       Impact factor: 10.122

3.  Kinetic analysis of the drug permeation process across the intestinal epithelium.

Authors:  S Yamashita; M Yoshida; Y Taki; T Sakane; T Nadai
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

4.  Experimental streptozotocin-reduced diabetes and intestinal glucose metabolism in the rat, in vivo and in vitro.

Authors:  M A Tormo; M A Gómez-Zubeldia; F Ropero; M Muñoz-Casillas; J C Moreno; J E Campillo
Journal:  Acta Diabetol       Date:  1995-10       Impact factor: 4.280

5.  Clinical trial of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men.

Authors:  M B Rabinowitz; H C Gonick; S R Levin; M B Davidson
Journal:  Biol Trace Elem Res       Date:  1983-12       Impact factor: 3.738

6.  Preservation of incretin activity after removal of gastric inhibitory polypeptide (GIP) from rat gut extracts by immunoadsorption.

Authors:  R Ebert; H Unger; W Creutzfeldt
Journal:  Diabetologia       Date:  1983-06       Impact factor: 10.122

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.